Bret Stephens’ Pharmapologetics
Now, when the demand for both innovation and access is high, it’s time to think outside the box and reevaluate the relationship between pharmaceutical drugs and the patent system. Perhaps a prize system is in order, or maybe a formal guarantee from firms receiving BARDA grants that the drugs will not be patented.Featured Publications
Spotlight on Criminal Justice: Observing PTACC National Deflection Week – July
Senate Spending Spree Same As It Ever Was
Legislative Lessons: How Three States Improved Access to HIV Prevention Medications
This IVF bill is a perfectly reasonable compromise. So, of course, Congress won’t pass it.